8-K ·Filed May 4, 2026

EW

Edwards Lifesciences Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001099800-26-000023
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

This is a routine CFO transition with a qualified external hire. No immediate trading signal. Monitor upcoming earnings calls for any strategic commentary under new CFO.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
EW ▲ +5.20% at T+60d
NEUTRAL call ✓ call won +5.20% · α vs SPY +2.72% · entry $82.63 → $86.92
Entry anchored
May 4, 2026
via day open
T+1d
+0.38%
call +0.38% · α -1.01%
$82.94
settled 5mo ago
T+5d
-3.85%
call -3.85% · α -5.83%
$79.45
settled 5mo ago
T+20d
+6.09%
call +6.09% · α +1.14%
$87.66
settled 4mo ago
T+60d
+5.20%
call +5.20% · α +2.72%
$86.92
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Edwards Lifesciences appoints Theodora Mistras as CFO, effective May 29, 2026, succeeding Scott Ullem in a planned transition. Mistras brings experience from Viatris and healthcare investment banking. The filing is a routine leadership change with no material financial impact.

Key Facts

  • Theodora Mistras appointed Corporate Vice President and CFO, effective May 29, 2026.
  • Mistras previously served as CFO of Viatris (NASDAQ: VTRS) and held senior roles at Citigroup and Goldman Sachs.
  • Base salary of $925,000, sign-on bonus of $2,013,000, initial RSU grant of $8,000,000, and annual equity grant of $4,500,000 for fiscal 2026.
  • Outgoing CFO Scott Ullem announced his planned transition in October 2025; no unexpected departure.

Financial Impact

Compensation package includes base salary $925k, sign-on bonus $2.013M, RSUs $8M, and annual equity $4.5M. No impact on company financials or guidance.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
74% bullish (43 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001099800-26-000023
Document: cfoofferletter.htm0001099800-26-000023
Document: a8-kxexpressreleasexcfo.htm0001099800-26-000023
Document: 0001099800-26-000023-index-headers.html0001099800-26-000023
Document: 0001099800-26-000023-index.html0001099800-26-000023
Document: 0001099800-26-000023.txt0001099800-26-000023
19 reports for EW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EW — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$90.74 $86.32▼ −4.87%▼ −5.19%$85.76 (−5.49%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$90.21 $86.29▼ −4.35%▼ −4.85%$85.76 (−4.93%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$89.95 $85.47▼ −4.99%▼ −4.88%$85.76 (−4.66%)
Aug 10, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$91.94 $86.72▼ −5.67%▼ −4.76%$85.76 (−6.72%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$86.07 $90.21▲ +4.81%▲ +1.82%$85.76 (−0.36%)
Jul 28, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$85.76 $90.78▲ +5.85%▲ +0.83%$85.76 (+0.00%)
May 29, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.17 $91.18▲ +3.42%▲ +5.73%$85.76 (−2.73%)
May 18, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$82.11 $88.58▲ +7.88%▲ +5.62%$85.76 (+4.45%)
May 18, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$82.11 $88.58▲ +7.88%▲ +5.62%$85.76 (+4.45%)
May 8, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$77.08 $87.54▲ +13.57%▲ +13.88%$85.76 (+11.27%)
Showing 10 of 19

US Market Status

Market Open — Closes in 4h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access